Status:

COMPLETED

Study of Blood Samples From Newborns With Down Syndrome

Lead Sponsor:

Children's Oncology Group

Collaborating Sponsors:

National Cancer Institute (NCI)

Conditions:

Myeloid Proliferations Associated With Down Syndrome

Eligibility:

All Genders

Up to 90 years

Brief Summary

This research study is looking at blood samples from newborns with Down syndrome. Studying the genes expressed in samples of blood from patients with Down syndrome may help doctors identify biomarkers...

Detailed Description

PRIMARY OBJECTIVES: I. To further our biological understanding of the natural history of transient myeloproliferative disorder (TMD) and its relationship to subsequent leukemia by facilitating the de...

Eligibility Criteria

Inclusion

  • Inclusion Criteria:
  • Diagnosis of transient myeloproliferative disorder (TMD) at \< 90 days of age and meeting 1 of the following criteria:
  • A diagnosis of Down syndrome or Down syndrome mosaicism AND non-erythroid and non-lymphoid blasts (any amount) in the peripheral blood verified with a second sample
  • Patients with typical physical characteristics of Down syndrome are allowed before cytogenetic or FISH confirmation of the diagnosis
  • Trisomy 21-positive leukemic blasts documented by biopsy of any organ (including \> 5% non-erythroid/non-lymphoid blasts documented by bone marrow aspirate or biopsy)
  • Infants with isolated trisomy 21 positivity identified only in the leukemic blasts are allowed
  • Institutional immunophenotype characterization is required for study enrollment

Exclusion

    Key Trial Info

    Start Date :

    February 23 2009

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ACTUAL

    End Date :

    September 30 2023

    Estimated Enrollment :

    180 Patients enrolled

    Trial Details

    Trial ID

    NCT00959283

    Start Date

    February 23 2009

    End Date

    September 30 2023

    Last Update

    October 3 2023

    Active Locations (189)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 48 (189 locations)

    1

    Children's Hospital of Alabama

    Birmingham, Alabama, United States, 35233

    2

    University of Alabama at Birmingham Cancer Center

    Birmingham, Alabama, United States, 35233

    3

    USA Health Strada Patient Care Center

    Mobile, Alabama, United States, 36604

    4

    Providence Alaska Medical Center

    Anchorage, Alaska, United States, 99508